# Post-Phase-2 Consolidation Handoff

## Repository state

- Repository: `DocDamage/chatbot`
- Audited integrated `main` commit: `6e1a019f8eccf5154c6a579d02abb188c6911a9e`
- Phase 2 implementation commit: `a0d159dd0eff1991a9a7400664e2eef0286e77a2`
- Integration pull request: `#155`
- Full green CI run: `31033387341`
- Branch-protection task: `P01-T07` owner-waived and closed as not planned
- Branch audit: `docs/implementation/BRANCH_CONSOLIDATION_2026-08-05.md`
- Date: `2026-08-05`

## Current status

- Phase 0 is verified.
- Phase 1 contains six verified tasks and one owner-waived task.
- All seven Phase 2 tasks are implemented, merged, and green in CI.
- Phase 2 task-specific evidence was not fully reconciled before integration, so the tasks remain `IMPLEMENTED_NOT_VERIFIED` rather than `VERIFIED`.
- Obsolete stacked PRs `#148`, `#149`, and `#150` are closed.
- Historical task branches are being removed after ancestry and merged-PR accounting.

## Owner governance decision

The repository owner does not want branch-protection rules. `main` remains intentionally unprotected. This does not authorize weakening CI, tests, security controls, evidence, or runtime QA.

## Next authorized work

`Phase 2 evidence closeout`

Create a fresh branch from the final consolidated `main` after the branch list temporarily contains only `main`.

The closeout must:

1. split the consolidated Phase 2 implementation evidence into task-specific P02-T01 through P02-T07 bundles;
2. record the exact implementation and integration commits, PR #155, CI run `31033387341`, changed files, commands, exit codes, and known limitations;
3. run the applicable repository checks against one exact closeout commit;
4. update the master tracker and release evidence index truthfully;
5. mark a task `VERIFIED` only when its own evidence and applicable QA requirements are complete;
6. replace and archive the handoff before authorizing Phase 3.

Do not begin Phase 3 implementation until this closeout is complete or the repository owner explicitly waives the Phase 2 evidence requirement.
